패밀리 비교 | 바이오정보모아 구조

유사도 계산 방법

보내기

KRAS G12C inhibitor chemical landscape

KRAS inhibitor

화합물 5
관계 7
SMILES 5/5

Drug: 5

KRAS G12C inhibitor chemical landscape. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.

Daraxonrasib · RAS(ON)

KRAS inhibitor

화합물 3
관계 1
SMILES 3/3

Drug: 1
Linker: 2

Non-covalent RAS(ON) multi-selective inhibitor. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.

KRAS G12D / RAS(ON) inhibitor series

KRAS inhibitor

화합물 3
관계 1
SMILES 3/3

Drug: 3

KRAS G12D / RAS(ON) inhibitor series. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.

패밀리 간 overlap

kras-g12c ↔ daraxonrasib · 평균 유사도(상위 쌍): 0.13
kras-g12c ↔ kras-g12d · 평균 유사도(상위 쌍): 0.15
daraxonrasib ↔ kras-g12d · 평균 유사도(상위 쌍): 0.24

Core 화합물 Morgan 유사도

Morgan 지문 r=2, 2048 bit, Tanimoto. 이 값은 효력, 생물활성, 안전성, 임상 효능을 예측하지 않습니다.

	KRAS G12C inhibitor chemical landscape	Daraxonrasib · RAS(ON)	KRAS G12D / RAS(ON) inhibitor series
KRAS G12C inhibitor chemical landscape	1.00	0.13	0.14
Daraxonrasib · RAS(ON)	0.13	1.00	0.15
KRAS G12D / RAS(ON) inhibitor series	0.14	0.15	1.00

유사도 계산 방법

보내기

KRAS G12C inhibitor chemical landscape

KRAS inhibitor

화합물 5
관계 7
SMILES 5/5

Drug: 5

KRAS G12C inhibitor chemical landscape. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.

Daraxonrasib · RAS(ON)

KRAS inhibitor

화합물 3
관계 1
SMILES 3/3

Drug: 1
Linker: 2

Non-covalent RAS(ON) multi-selective inhibitor. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.

KRAS G12D / RAS(ON) inhibitor series

KRAS inhibitor

화합물 3
관계 1
SMILES 3/3

Drug: 3

KRAS G12D / RAS(ON) inhibitor series. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.

패밀리 간 overlap

kras-g12c ↔ daraxonrasib · 평균 유사도(상위 쌍): 0.13
kras-g12c ↔ kras-g12d · 평균 유사도(상위 쌍): 0.15
daraxonrasib ↔ kras-g12d · 평균 유사도(상위 쌍): 0.24

Core 화합물 Morgan 유사도

Morgan 지문 r=2, 2048 bit, Tanimoto. 이 값은 효력, 생물활성, 안전성, 임상 효능을 예측하지 않습니다.

	KRAS G12C inhibitor chemical landscape	Daraxonrasib · RAS(ON)	KRAS G12D / RAS(ON) inhibitor series
KRAS G12C inhibitor chemical landscape	1.00	0.13	0.14
Daraxonrasib · RAS(ON)	0.13	1.00	0.15
KRAS G12D / RAS(ON) inhibitor series	0.14	0.15	1.00